• Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Average Recommendation of "Buy" from Analysts

    Source: Buzz FX / 26 Jan 2025 03:36:18   America/Chicago


    Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat January 26, 2025 Share Link copied to clipboard. Shares of Catalyst Pharmaceuticals, Inc.
    Read more...
Share on,